Medicare utilization — MARC SLONIMSKI (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 2,860 | 16 | $0 | $28,734 |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,795 | 12 | $0 | $8,827 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 588 | 57 | $0 | $491 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 342 | 106 | $0 | $32,233 |
| J0475 | Injection, baclofen, 10 mg | 261 | 20 | $0 | $37,069 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·